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ABSTRACT
Background
Mediastinitis as a complication after car-
diac surgery is rare but disastrous, increas-
ing hospital stay, hospital costs, morbidity, 
and mortality. It occurs in  –   of patients 
after median sternotomy. Studies on risk 
factors exist, but the results are confl icting. 
Th e aims of this study were to determine the 
risk factors in the Finnish population and to 
investigate new ways of preventing medias-
tinitis.
Patients and methods
Th e subject pool comprised patients un-
dergoing sternotomy or thoracotomy dur-
ing cardiovascular surgery with cardiopul-
monary bypass between  and . 
Most surgeries entailed coronary artery 
bypass grafting (CABG). First, we assessed 
operating room air contamination moni-
toring by comparing the bacteriological 
technique with continuous particle count-
ing in low level contamination achieved 
by ultraclean garment options in  CABG 
operations. Second, we examined surgical 
glove perforations and changes in bacte-
rial fl ora of surgeons’ fi ngertips in  
open-heart procedures. Th ird, the eff ect 
of a gentamicin-collagen sponge on pre-
venting surgical site infections (SSIs) was 
studied in a randomized controlled study 
with  participants. Finally, incidence, 
outcome, and risk factors of mediastinitis 
were evaluated in patients operated on 
during  – . Data were recorded 
prospectively in an operating room log, 
hospital discharge register, and the hospi-
tal’s cardiothoracic unit register. Cases of 
mediastinitis were identifi ed from the hos-
pital infection register, and patients’ charts 
were reviewed.
Main results
With the alternative garment and textile 
system (cotton group and clean air suit 
group), the air counts fell from  colony-
forming units (CFU) / m to   CFU / m. 
Contamination of the sternal wound was 
reduced by   and that of the leg wound 
by >  . When an air particle level ≤  
particles / m is reached, the bacterial air 
contamination is of the magnitude of that 
of orthopedic hip operations. Th e staff  must 
during the entire operation adjust their ac-
tivity to air asepsis.
Glove perforations occurred in the ma-
jority of heart operations. In only   of 
operations were both gloves unpunctured. 
Frequency of glove perforations and bacte-
ria counts on hands were found to increase 
with duration of surgery.
In the randomized study with local gen-
tamicin-collagen sponge prophylaxis, SSI 
occurred in  of  patients (. ) in the 
study group and in  of  patients (. ) 
in the control group. Th is diff erence was not 
statistically signifi cant. Th ere were three 
cases of mediastinitis (. ) in the study 
group and fi ve (. ) in the control group.
We identifi ed  /    cases of post-
operative mediastinitis (. ) over the -
year period. During the study period, the 
patient population grew signifi cantly older, 
the proportion of women and patients with 
an American Society of Anesthesiologists 
(ASA) score >  increased signifi cantly. In 
multivariate logistic regression analysis, the 
only signifi cant predictor for mediastinitis 
was obesity.
Conclusions
Continuous particle monitoring is a good 
intraoperative method to control air con-
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tamination related to theater staff  behavior 
during operations. When a glove puncture 
is detected, both gloves should be changed. 
Before donning a new pair of gloves, re-
newed disinfection of hands will help to 
keep bacterial counts lower, particularly 
towards the end of a long operation. A gen-
tamicin-collagen sponge may have benefi -
cial eff ects on prevention of SSI, but further 
research is needed. Th e prevalence of me-
diastinitis is not diminishing. Changes in 
the populations at risk, with, for example, 
the increasing proportion of overweight 
patients, reinforce the importance of sur-
veillance and pose a challenge in focusing 
preventive measures.
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ABBREVIATIONS
ASA American Society of Anesthesiologists
BITA bilateral internal thoracic artery
BMI body mass index
CABG coronary artery bypass grafting
CDC Centers for Disease Control and Prevention
CFU colony-forming unit
CI confi dence interval
COPD chronic obstructive pulmonary disease
CRP C-reactive protein
EF left ventricular ejection fraction
ICU intensive care unit
ITA internal thoracic artery
IV intravenous
MIC minimum inhibitory concentration
MRSA methicillin-resistant Staphylococcus aureus
MRSE methicillin-resistant Staphylococcus epidermidis
NNIS National Nosocomial Infections Surveillance
NYHA New York Heart Association
OR odds ratio
SENIC Study on the Effi  cacy of Nosocomial Infection Control
SSI surgical site infection
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1 INTRODUCTION
Modern surgical practices have reduced the 
rate of wound infections markedly. However, 
no reduction has occurred in infection rates 
during the late th century, despite further 
developments in surgical techniques and 
antimicrobial prophylaxis. Surgical patients 
tend to be sicker and to undergo more com-
plex operations. Surgical site infections 
(SSIs) have enormous clinical and fi nancial 
implications. Higher infection rates trans-
late into higher morbidity and mortality as 
well as higher costs to the hospital, patient, 
and society as a whole.
Mediastinitis after cardiac surgery is a very 
serious complication, which raises hospital 
costs, suff ering, and mortality. Fortunately, 
mediastinitis is rare, occurring in only  –   
of patients (Loop et al. ; Higgins et al. 
; Farinas et al. ; Milano et al. ; 
Valla et al. ; Ståhle et al. ; DiPiro et 
al. ) (Tables  and ).
Although cardiologists are able to treat 
more patients with coronary artery disease, 
the aff ected population is becoming in-
creasingly older. Moreover, coronary artery 
bypass grafting (CABG) surgery remains 
necessary and may even be on the rise. 
Furthermore, patients undergoing cardiac 
surgery are sicker than they were a few years 
ago, which has resulted in an increase in 
the number of postoperative complications 
(Quaini et al. ). Th us, every eff ort to 
understand the etiology and reduce the in-
cidence of SSIs is justifi ed.
Prevention of SSIs requires antisepsis, 
asepsis, perioperative antimicrobial prophy-
laxis, good surgical technique, preoperative 
identifi cation of patients at risk, and addi-
tional individualized preventive measures. 
Various risk factors for mediastinitis have 
been suggested in numerous large studies. 
Th ese include obesity, diabetes mellitus, 
smoking, use of bilateral internal thoracic 
artery as graft material, prolonged mechani-
cal ventilation, and reoperation of the chest. 
However, study results are often confl ict-
ing. Research designs vary, with some be-
ing retrospective and others prospective, 
study populations are often small, wound 
infection defi nitions are diff erent, and su-
perfi cial wound infections are sometimes 
included. Th ese inconsistencies make it dif-
fi cult to compare fi ndings. Risk factors for 
SSIs after cardiac surgery have been studied 
in the Finnish population (Vuorisalo et al. 
), but they may not be the same for me-
diastinitis (Olsen et al. ), which has not 
been investigated in this context in Finland. 
Performing this risk factor study on our 
Finnish population thus was warranted.
As an SSI is one of the most feared com-
plications after cardiac surgery, keeping the 
operating room contamination at the low-
est possible level is essential. Two separate 
studies of cardiac operations have shown 
that improving the surgical environment, 
refi ning surgical and operating room pro-
tocols, and increasing the awareness of the 
dangers of infection among personnel can 
reduce the infection rate (Ferrazzi et al. 
; Rao et al. ). Th e operating room 
environment has been widely investigated 
concerning scrub suits, surgical attire and 
drapes, patient skin preparation, preopera-
tive hand antisepsis, glove perforations, and 
ventilation, but little is known about the 
operating room air contamination control 
or the impact of glove perforations on the 
bacterial fl ora on a surgeon’s hands.
Th e benefi cial eff ect of antimicrobial pro-
phylaxis on wound infections was already 
demonstrated in the s (Burke ; Polk 
and Lopez-Mayor ; Stone et al. ). 
Today, it is clear that antimicrobial prophy-
laxis is essential in cardiac surgery, reducing 
the risk of SSIs by a factor of fi ve (Kreter and 
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Woods ). Locally administered antibi-
otics have been used successfully to treat 
wound infections, but there is little experi-
ence on their use as prophylactic agents. For 
instance, local antimicrobial prophylaxis 
with gentamicin was not investigated in car-
diac surgery before .








Loop 1990 6504 1.1 14
Wouters 1994 1368 1.7 30
Farinas 1995 3645 0.9 35
Milano 1995 6459 1.3 12
Valla 1996 9814 1.0 39
Muñoz 1997 3711 2.2 18
Ståhle 1997 13285 1.5 4
Bitkover 1998 1935 2.1 12
Gårdlund 2002 9557 1.3 19
Abboud 2004 9136 0.5 23
Fowler 2005 331429 0.9 17
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2 REVIEW OF THE LITERATURE
. Surgical site infections
Surgical site infections are the most com-
mon nosocomial infection among surgical 
patients (Mangram et al. ). According to 
Centers for Disease Control and Prevention 
(CDC) defi nitions, they can be classifi ed into 
three categories: superfi cial incisional SSIs 
(involving only skin and subcutaneous tis-
sues), deep incisional SSIs (involving deep 
soft tissue), and organ / space SSIs (involving 
any part of the body other than the incision 
itself that is opened or manipulated during 
the operative procedure). Th e categories of 
SSI in open-heart surgery via sternotomy are 
presented in Figure . Furthermore, accord-
ing to the CDC, mediastinitis must meet at 
least one of the following criteria: ) positive 
bacterial culture from the mediastinal space, 
) evidence of mediastinitis during a surgery 
or histology, and ) one of the following: fe-
ver (>  °C), chest pain, or sternal instability, 
and at least one of the following: purulent 
discharge from the mediastinal area, organ-
isms cultured from blood or from the dis-
charge of the mediastinal area, or mediasti-
nal widening in radiology (Horan et al. ) 
(Table ). In the literature, various terms for 
chest SSIs have been used, including sternal 
infection, deep sternal infection, and major 
infection. Th e inconsistent defi nitions make 
it diffi  cult to compare results.
Several studies exist on incidence of SSI 
after cardiac surgery. Most have included 
mediastinitis or all types of SSI, with infec-
tion being poorly defi ned. In large retrospec-
tive studies dated before , comprising 
over   patients, the mediastinitis rate 
varied between .  and .  (Ottino et al. 
; Hammermeister et al. ; Loop et 
al. ; Milano et al. ; Valla et al. ) 
(Table ). Th ree prospective works pub-
lished after  by Gårdlund et al. (), 
Lu et al. (), and Lepelletier et al. () 
showed similar rates (. – . ). In three 
case-control studies, the rates were . , 
. , and .  (Muñoz et al. ; Bitkover 
and Gårdlund ; Abboud et al. ).
Microbial contamination of the wound is 
necessary for infection to develop. Th e risk 
of SSI can be estimated by the following re-
lationship (Cruse ): 
DOSE OF BACTERIAL CONTAMINATION × VIRULENCE 
RESISTANCE OF THE HOST PATIENT
= RISK OF SSI
Figure 1. Cross-section of thoracic wall depicting CDC classifi cations of surgical site 
infections (SSIs).
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Table 3. Criteria for defi ning a surgical site infection (SSI) (Horan et al. 1992).
Superfi cial incisional SSI
Infection occurs within 30 days after the operation and infection 
involves only skin or subcutaneous tissue of the incision and at least 
one of the following: 
1. Purulent drainage, with or without laboratory confi rmation, from 
the superfi cial incision.
2. Organisms isolated from an aseptically obtained culture of fl uid 
or tissue from the superfi cial incision.
3. At least one of the following signs or symptoms of infection: pain 
or tenderness, localized swelling, redness, or heat and superfi cial 
incision is deliberately opened by surgeon, unless incision is 
culture-negative.
4. Diagnosis of superfi cial incisional SSI by the surgeon or attending 
physician.
Deep incisional SSI
Infection occurs within 30 days after the operation if no implant is 
left in place or within 1 year if implant is in place and the infection 
appears to be related to the operation and infection involves deep 
soft tissues (e.g., fascial and muscle layers) of the incision and at least 
one of the following: 
1. Purulent drainage from the deep incision but not from the 
organ / space component of the surgical site.
2. A deep incision spontaneously dehisces or is deliberately opened 
by a surgeon when the patient has at least one of the following 
signs or symptoms: fever (>  38  ºC), localized pain, or tenderness, 
unless site is culture-negative.
3. An abscess or other evidence of infection involving the deep 
incision is found on direct examination, during reoperation, or by 
histopathologic or radiologic examination.
4. Diagnosis of a deep incisional SSI by a surgeon or attending 
physician.
Organ / Space SSI
Infection occurs within 30 days after the operation if no implant is 
left in place or within 1 year if implant is in place and the infection 
appears to be related to the operation and infection involves any 
part of the anatomy (e.g., organs or spaces), other than the incision, 
which was opened or manipulated during an operation and at least 
one of the following: 
1. Purulent drainage from a drain that is placed through a stab 
wound into the organ / space.
2. Organisms isolated from an aseptically obtained culture of fl uid 
or tissue in the organ / space.
3. An abscess or other evidence of infection involving the 
organ / space that is found on direct examination, during 
reoperation, or by histopathologic or radiologic examination.
4. Diagnosis of an organ / space SSI by a surgeon or attending 
physician.
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Th e pathogens involved in SSIs after 
cardiac surgery are mainly Staphylococcus 
epidermidis and Staphylococcus aureus 
(Th e Parisian Mediastinitis Study Group 
; Tegnell et al. ; Sharma et al. 
). Coagulase-negative staphylococci 
have recently become the most important 
pathogen, especially in deep incisional or 
organ / space SSIs (Tegnell et al. ). Th e 
fi nding that methicillin-resistant S. aureus 
strains (MRSA) have become more com-
mon is worrisome. In a recent report from 
New Zealand,   of the S. aureus iso-
lated in poststernotomy mediastinitis was 
methicillin-resistant (Upton et al. ). In 
another report from Australia (comprising 
 patients),   of organisms isolated 
from sternal wounds were MRSA strains 
(Harrington et al. ). Th is presents new 
challenges for prevention and treatment of 
these infections.
Th e clinical picture of mediastinitis var-
ies from fulminant septic infection to vague 
clinical symptoms. El Oakley and Wright 
() have presented a classifi cation of 
mediastinitis as follows: type I mediastini-
tis presents within  weeks after operation 
in the absence of risk factors (e.g. diabetes, 
obesity, and use of immunosuppressive 
agents); type II mediastinitis presents at 
 –  weeks after operation in the absence of 
risk factors; type III mediastinitis comprises 
types I and II in the presence of risk factors; 
type IV mediastinitis includes types I – III af-
ter a failed therapeutic surgical intervention; 
and type V presents for the fi rst time more 
than  weeks after operation and is charac-
terized by chronic smoldering osteomyelitis 
with draining sinus tracts, leading to necrot-
ic areas of bone or costal cartilages.
Treatment of mediastinitis varies from 
simple prolonged antibiotic therapy to com-
plete sternectomy combined with a major 
plastic procedure. Antibiotic therapy alone 
is occasionally suffi  cient, but surgical inter-
vention is usually required. Th e most com-
mon technique entails wound debridement, 
primary sternal closure, and closed medias-
tinal catheter irrigation. Types IV and V may 
be treated by wound debridement, sternec-
tomy, excision of exposed costal cartilage 
if necessary, and muscle or omental fl ap 
repair (El Oakley and Wright, ).
Bitkover and colleagues () studied 
the sources of coagulase-negative staphylo-
cocci in sternal wounds during operations 
done in an ultraclean environment, and 
found that bacteria in the sternal wound 
originated from patients’ skin and from the 
surgical team. For the majority of SSIs, the 
source of pathogens is patients themselves 
(Altemeier and Culbertson ; Haas et 
al. ). In patients who have a prosthesis 
implanted during surgery, the pathogens 
can derive from a distant focus of infec-
tion (Slaughter et al. ; Edwards ; 
Valentine et al. ; Stuesse et al. ). Th e 
pathogens may also come from exogenous 
sources, including surgical team members, 
operating room air, tools, instruments, and 
materials brought to the sterile fi eld during 
surgery (Whyte et al. ; Verkkala et al. 
; Tammelin et al. a).
. Risk factors for mediastinitis
In the early s, the Study on the Effi  cacy 
of Nosocomial Infection Control (SENIC) 
identifi ed three risk factors in addition to 
wound class: location of operation, dura-
tion of operation, and patient clinical status 
(Haley et al. ). Th e National Nosocomial 
Infections Surveillance (NNIS) study re-
duced these four risk factors to three: wound 
classifi cation, length of operation > T hours 
(where T is the approximate th percentile 
of the duration of the specifi c operation), 
and American Society of Anesthesiologists 
(ASA) score >  (Culver et al. ; Mangram 
et al. ). Both risk assessments integrate 
three determinants of infection: bacteria 
(wound class), local environment (dura-
tion), and systemic host defense (patient 
health status). However, the SENIC and 
NNIS assessments do not integrate other 
known risk variables, such as smoking, tis-
sue oxygen tension, glucose control, shock, 
and maintenance of normothermia. In car-
diac surgery, these risk indices yield little in-
formation since the wounds are always clean 
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(wound class I) and the patient’s ASA score 
is almost always  or worse. Consequently, 
the most important issue is the duration of 
the operation. Th e Northern New England 
Cardiovascular Disease Study Group has 
calculated a score not only for risk for mor-
tality and cerebrovascular accident but also 
for mediastinitis in isolated CABG surgery. 
In this mediastinitis score, the patient re-
ceives  points when left ventricular ejection 
fraction (EF) <  , . points for urgent sur-
gery, . points for emergency surgery, . 
points for diabetes, . points for dialysis or 
creatinine ≥  mg/dl, . points for chronic 
obstructive pulmonary disease (COPD), . 
points for obesity (body mass index (BMI) 
 –  kg / m) and . points for severe obe-
sity (BMI ≥  kg / m). Perioperative risk for 
mediastinitis is   with score , .  with 
score ,   with score , and ≥ .  with 
score  (Eagle et al. ).
Knowledge of risk factors may enable 
targeted preventive measures. Reviewing 
previous risk factor studies (Table ), there 
is no doubt that obesity predisposes not 
only to sternal superfi cial incisional SSI 
but also to mediastinitis. It has been a sig-
nifi cant risk factor in many well-conducted 
large studies (Loop et al. ; Milano et 
al. ; Th e Parisian Mediastinitis Study 
Group, ; Valla et al. ; Antunes et al. 
; Bitkover and Gårdlund ; Abboud 
et al. ; Harrington et al. ; Fowler 
et al. ). Nevertheless, in some studies 
obesity was not investigated (Ottino et al. 
; Hammermeister et al. ; Muñoz 
et al. ; Ståhle et al. ), and in one 
study (Wouters et al. ) it was not a sig-
nifi cant risk factor; however the study popu-
lation was small, comprising only  cases 
of mediastinitis. Th e evidence is therefore 
strong for obesity’s infl uence on medias-
tinitis. Overweight is associated with type 
II diabetes mellitus. As a known possible 
risk factor for infections, diabetes has been 
included in nearly every risk factor study. 
Diabetes has been verifi ed to be a predictor 
of mediastinitis in many reports (Loop et al. 
; Wouters et al. ; Valla et al. ; 
Antunes et al. ; Ståhle et al. ; Trick 
et al. ; Lu et al. ; Harrington et al. 
; Fowler et al. ). However, in sev-
eral others, it has not been a signifi cant risk 
factor (Grossi et al. ; Farinas et al. ; 
Milano et al. ; Th e Parisian Mediastinitis 
Study Group, ; Muñoz et al. ; 
Bitkover and Gårdlund ; Abboud et 
al. ). Recently, more information has 
been uncovered about diabetes. Furnary et 
al. () showed that perioperative con-
tinuous intravenous insulin infusion lowers 
the incidence of mediastinitis in diabetic 
patients. In Trick and colleagues’ study in 
, diabetes mellitus with a perioperative 
blood glucose level of  mg / dl or more 
was demonstrated to be an independent 
risk factor for mediastinitis. Furthermore, 
in another study, diabetes and postopera-
tive hyperglycemia were independently as-
sociated with SSIs (sternal and leg) among 
cardiothoracic surgery patients, and   of 
patients had undiagnosed diabetes (Latham 
et al. ).
Th e internal thoracic artery (ITA) as graft 
material has proven superior, but use of both 
thoracic arteries has increased infectious 
complications. In the large subject pool of 
Grover et al. () (   patients), bilat-
eral ITA (BITA) use was associated with an 
increase in mediastinitis. Th is is consistent 
with several studies (Loop et al. ; Grossi 
et al. ; Th e Parisian Mediastinitis Study 
Group ; Antunes et al. ). In some 
reports, however, use of BITA was not found 
to be a risk factor for mediastinitis (Wouters 
et al. ; Abboud et al. ). In Lu’s study, 
BITA was a signifi cant risk factor for super-
fi cial incisional SSI but not for deep inci-
sional or organ / space SSI (Lu et al. ). 
Th is risk factor was impossible to evaluate 
in some studies due to small subject popu-
lation (Bitkover and Gårdlund ), and in 
other reports it was not investigated (Ottino 
et al. ; Blanchard et al. ; Muñoz 
et al. ). Even though BITA was not a 
predictor of mediastinitis in Loop’s study, 
combined with diabetes, the risk increased 
fi vefold (Loop et al. ). In recent reports, 
however, skeletonization of both ITAs sig-
nifi cantly decreased the risk compared with 
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harvesting in a pedicled fashion (De Paulis 
et al. ). In diabetics, no diff erence was 
observed in incidence of mediastinitis 
among patients receiving a single ITA or a 
double skeletonized ITA (Matsa et al. ; 
Peterson et al. ; De Paulis et al. ). 
Although one might speculate that use of 
BITA would be ill-advised when operating 
on the elderly, bilateral skeletonized ITA has 
been reported to carry relatively low mor-
bidity and mortality also in patients over  
years (Kramer et al. ).
While old age has been confi rmed to 
be a risk factor for SSIs in certain types of 
surgeries, many studies in cardiac surgery 
show that age does not compromise sternal 
SSIs (Ottino et al. ; Hammermeister 
et al. ; Loop et al. ; Th e Parisian 
Mediastinitis Study Group ; Antunes 
et al. ; Muñoz et al. ; Ståhle et al. 
). Moreover, old age may not be a risk 
factor for SSI in some other types of op-
erative procedures. Kaye et al. () found 
that age was a strong predictor of SSI until 
the age of  years, but beyond this age a de-
creased risk of SSI was observed.
S. aureus causes   of nosocomial in-
fections. From   to   of the popula-
tion carries this pathogen in the nares (Perl 
and Golub ). Carriers are at higher risk 
for SSIs (Perl and Golub ), also after 
cardiac surgery (Kluytmans et al. ). 
S.  aureus can be eradicated eff ectively from 
the nares with mupirocin ointment. One 
study showed a decrease in SSI rate in car-
diothoracic surgery when mupirocin was 
applied preoperatively to nares. However, 
the patients were compared with previous 
surgical patients (historical controls), and 
thus, there might also be other reasons for 
the reduction in SSI rate (Kluytmans et al. 
). In a prospective randomized study 
with  patients, mupirocin did not lower 
the rate of S. aureus SSIs (Perl et al. ). 
Screening of nasal carriers thus far is not 
recommended.
Additional risk factors can be found 
in the literature. Smoking delays primary 
wound healing and may increase the risk of 
SSI. In a large prospective study, cigarette 
smoking was an independent risk factor for 
SSIs following cardiac surgery (Abboud et 
al. ). However, most large studies have 
not investigated this relationship, perhaps 
because information about smoking hab-
its is not often reliable. Occasionally, other 
risk factors, such as previous heart surgery, 
preoperative hospital stay, emergency op-
eration, prolonged mechanical ventilation, 
reoperation, blood transfusions, and COPD, 
are signifi cant in diff erent studies (Table ). 
Overall, the results are confl icting and con-
fusing. Many studies are retrospective, the 
subject populations are small, wound infec-
tion defi nitions vary, and superfi cial inci-
sional SSIs are included, all of which makes 
it diffi  cult to compare fi ndings.
. Operating room practices
Several possibilities exist on how to infl u-
ence the infection risk in the operating 
room. Informing the surgeons of their re-
spective wound infection rates leads to a 
reduction in infection risk through better 
aseptic operative techniques and improved 
teamwork (Mangram et al. ). Although 
a preoperative antiseptic shower reduces 
the microbial colony count on the patient’s 
skin, no evidence has emerged that it low-
ers the infection rate (Ayliff e et al. ; 
Lynch et al. ). Shaving the hair from 
the incision site, especially the night be-
fore surgery, increases the infection risk. 
Instead, hair should be clipped just prior to 
surgery (Cruse and Foord ; Geelhoed et 
al. ; Woodhead et al. ) or perhaps 
not clipped at all (Mishriki et al. ; Th e 
Parisian Mediastinitis Study Group ).
Th in, transparent plastic adhesive incise 
drapes reduce wound contamination, but 
microbial counts beneath the drape reach 
normal levels within three hours. Iodophor-
impregnated incise drape eliminates skin 
colonization for three hours (Johnston et al. 
), but there is no evidence that it lowers 
the incidence of SSI.
Some other practices have been shown to 
reduce infection rates. Dramatic reductions 
in SSI rates have been achieved through 
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careful avoidance of hypothermia (Kurz et 
al. ; Melling et al. ). However, in 
cardiac surgery, hypothermia is often nec-
essary and cannot be avoided. Excessive 
temperatures are also deleterious. Evidence 
suggests that among diabetics a peak core 
body temperature of > . °C during car-
diopulmonary bypass is a signifi cant risk 
factor for mediastinitis (Groom et al. ). 
Supplemental oxygen administration (FiO

 
>  ) may decrease infection rates in 
colorectal surgery (Greif et al. ; Belda et 
al. ).
. Air asepsis
Th e purpose of achieving particle-free air 
(i.e. “ultraclean air”) is logical in heart sur-
gery where operations are long, numerous 
people are present in the operating theater, 
and the consequences of infection are of-
ten serious (Gnann and Dismukes ; 
Sarr et al. ). In , Sir John Charnley 
published the results for  total hip re-
placements performed under ultraclean air 
technology without prophylactic antibiot-
ics. Incidence of deep wound infection fell 
from   to .  (Charnley ). At the 
same time, prophylactic antibiotics were 
introduced, proving to be the single most 
eff ective measure in reducing incidence of 
SSI in  years.
Low bacterial contamination of the air 
has been shown to have an additional eff ect 
of preventing infections in orthopedic sur-
gery. Th is may be achieved by ventilation, 
special clothing, and high standards for 
staff  hygiene (Lidwell et al. ). Particles 
can originate from people, equipment, and 
surface shedding. Airfl ow design within a 
clean space is used as an aid to remove con-
tamination from these internal sources. Th e 
proposed maximum level of air contamina-
tion for orthopedic surgery is ≤  colony-
forming units (CFU) / m measured  cm 
above the wound (Whyte et al. ). A di-
rect correlation between air contamination 
and wound infection has been shown in hip 
operations (Lidwell et al. ).
To obtain a clean environment in a sur-
gical theater, particular attention must be 
paid to airfl ow pattern control and removal 
of particles and microorganisms from the 
space. Th e operating room doors must 
be kept closed except for the passage of 
equipment, personnel, and patients, and 
personnel traffi  c should be minimized be-
cause the air contamination level is directly 
proportional to the number of people mov-
ing in and out of the room (Ayliff e ). 
Operating theaters should be maintained 
at positive-pressure ventilation with respect 
to corridors and adjacent areas (Lidwell 
; Mangram et al. ; Th e American 
Institute of Architects and Th e Facilities 
Guidelines Institute ). In a convention-
ally ventilated operating theater, a mini-
mum of  total air changes, three of which 
are fresh air, should occur per hour (Clark 
et al. ; Nichols ; Th e American 
Institute of Architects and Th e Facilities 
Guidelines Institute ). All recirculated 
and fresh air should be fi ltered through the 
appropriate fi lters, providing at least   
effi  ciency (dust-spot testing) (Babb et al. 
). Moreover, air should be introduced 
at the ceiling and exhausted near the fl oor 
(Laufman ; Lidwell ; Th e American 
Institute of Architects and Th e Facilities 
Guidelines Institute ). Ultraviolet (UV) 
light is not recommended since it has not 
been shown to prevent SSIs (Collis and 
Steinhaus ; Lidwell et al. ; Taylor et 
al. ).
Traditionally, ultraclean air has been 
achieved with the help of ventilation sys-
tems. Laminar airfl ow is designed to move 
particle-free air over the aseptic operating 
fi eld, sweeping away particles in its path. 
In a laminar airfl ow system, recirculated air 
is usually passed through a high-effi  ciency 
particulate air (HEPA) fi lter (Hambraeus 
; Friberg ). Laminar airfl ow has 
been suggested as an additional measure 
to reduce SSI risk in certain operations 
(e.g. some cardiac surgeries, neurosurgery, 
implant surgery theaters, and transplant 
units), and it is used widely in many centers 
even though its eff ect on reducing infec-
tions is controversial (Lidwell et al. ). 
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Most of the studies examining the effi  cacy 
of ultraclean air have done this only in con-
junction with orthopedic operations, and 
some have shown ultraclean air to be eff ec-
tive (Howorth ; Gruenberg et al. ). 
A large study of  orthopedic implant 
operations revealed that ultraclean air and 
antimicrobial prophylaxis both reduce inci-
dence of SSIs, but the latter was more ben-
efi cial (Lidwell et al. ). In a recent study, 
wound contamination in laminar fl ow and 
standard operating theaters was compared, 
and no signifi cant diff erence was found 
(Clarke et al. ).
For an effi  cient laminar airfl ow system, 
the fi lter ceiling must be suffi  ciently large, 
covering the whole aseptic working area, in-
cluding instrumentation. Disadvantages are 
that the system is expensive, and opening 
doors and movement of personnel disturb 
the airfl ow. Th is system is best utilized in 
operations that demand the highest clean-
liness (e.g. transplant surgery, prosthesis 
implantation, or surgery on immunosup-
pressive patients), but its benefi t is realized 
only if the hygiene of personnel is strict, the 
scrub team wears special exhaust suits, and 
the doors of the operating theater are kept 
closed (Knobben et al. ). 
Another means of lowering the number 
of airborne bacteria to reach the wound 
is the use of special scrub suits or gowns. 
Earlier studies, both in the laboratory and 
during surgery, have shown that specially 
designed working clothes, a polypropylene 
coverall, worn by all present in the theater, 
keep the level of microbial contamination 
in theater air during orthopedic surgeries 
low (Blomgren et al. ; Whyte et al. ; 
Bergman et al. ). Also in cardiac surgery, 
the use of a combined system of disposable 
gowns, drapes, and staff  clean air suits re-
duces bacterial air contamination (Verkkala 
et al. ). However, wearing special scrub 
suits (tightly woven and cuff s at the wrists 
and ankles) did not infl uence the air counts 
or wound contamination with methicillin-
resistant S. epidermidis (MRSE). With regard 
to S. aureus, a signifi cantly lower air count 
was identifi ed, but no eff ect was observed 
for wound contamination rates (Tammelin 
et al. a, b). If a laminar ventilation 
system was used in combination with body 
exhaust gowns, the contamination of the 
operative fi eld could be brought to a very 
low level (Blomgren et al. ).
A healthy individual disperses thousands 
of bacteria-carrying skin particles per minute 
during walking. Th e airborne particles con-
taminate wounds directly by sedimentation 
or indirectly by fi rst settling on instruments 
or other items that are then brought into con-
tact with the wound. Various air sampling 
methods, e.g. slit samplers, fi lter samplers, 
and sedimentation plates, have been used 
to monitor microbial contamination (Table 
). Th ese techniques are, however, awkward 
to perform, and the results are only available 
several days after the operation. Particulate 
contamination, on the other hand, may be 
Table 4. Measurement principles for airborne microorganisms.
Method Function
Volumetric method
Impaction Air with microorganisms is sucked through a slit or hole with such high speed that 
the microorganisms strike an agar surface and are trapped (and grow on it when 
incubated)
Centrifugal Air with microorganisms is sucked axially by a fan blade and then moved radially 
at such high speed that particles hit the inside wall of the fan chamber and are 
trapped on agar (and grow when incubated)
Filtering Air with microorganisms is sucked through a fi lter and microorganisms are trapped 
on a membrane fi lter and then transferred to a nutrient agar surface and incubated
Settle plate method
Sedimentation Microorganisms in the air are allowed to settle, over a specifi ed time, on a dish 
containing nutrient agar medium, which is then incubated
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readily and continuously monitored on the 
spot via computerized electronic equipment 
(Seal and Clark ). A prerequisite for using 
this technique is, however, the maintenance 
of very low particle counts. No agreement 
exists regarding tolerable levels of particles 
in operating rooms or the most suitable 
method for air monitoring. Evaluation of 
air quality can be performed by microbio-
logical sampling or particle counting. Th e 
relationship between these two methods 
has rarely been examined. In a recent study, 
particle counting and microbiological sam-
pling of air did not correlate, and the authors 
concluded that replacing microbiological 
sampling with particle counting for routine 
evaluation of microbiological contamina-
tion in conventionally ventilated operating 
rooms is not warranted (Landrin et al. ). 
However, the operating rooms were empty, 
and the results might have been diff erent 
had there been people shedding infectious 
particles to the air.
. Perforations in surgical gloves
One possible contamination route in the 
operating room environment is a perforated 
glove. Th e purpose of surgical gloves is to 
create a barrier between the operating staff  
and the patient, thereby protecting both 
from microbial infections. In unused surgi-
cal gloves, the puncture rate varies between 
.  and .  (Russell et al. ; Paulssen 
et al. ; Albin et al. ). Today, the in-
dustry standard for holes is an acceptance 
quality (AQL) of .  according to the EU 
directives. During operations high perfora-
tion rates ( –  ) have been described in 
heart surgery (Berg et al. ; Wong et al. 
; Driever et al. ). In other types of 
surgical procedures, the glove perforation 
rate varies from   to   (Maff ulli et al. 
; Jensen et al. ; Hollaus et al. ; 
Naver and Gottrup ; Laine and Aarnio 
). Double gloving is considered to pro-
vide an additional barrier and to further 
reduce the risk of contamination. Th is has 
been confi rmed in many studies (Jensen 
et al. ; Caillot et al. ; Naver and 
Gottrup ; Laine and Aarnio ). Th e 
 Cochrane review also concluded that 
wearing double gloves signifi cantly reduced 
perforations of the innermost glove (Tanner 
and Parkinson ).
Protecting healthcare workers from in-
fectious diseases such as hepatitis B, hepa-
titis C, and acquired immunodefi ciency 
syndrome (AIDS) has become more im-
portant in recent years. Open-heart proce-
dures carry a high risk of puncture injury 
and frequent exposure to blood, increasing 
the risk of the surgical team acquiring viral 
infections from the patient (Kjaergard et al. 
). Alternatively, some reports have indi-
cated that surgeons may transmit hepatitis B 
or C to patients (Esteban et al. ; Harpaz 
et al. ).
 Most punctures are not noticed by oper-
ating staff  when donning the gloves (Berg et 
al. ; Naver and Gottrup ; Laine and 
Aarnio ). Avoidance of glove perfora-
tions and in their event quick detection are 
therefore of the utmost importance during 
surgery. How large a hole must be to allow 
microorganisms to enter or exit a glove is 
unknown. Small pinholes might be safe be-
cause they often close immediately and may 
even go undetected in the water test. Large 
holes are, however, a risk factor for both the 
patient and the operator.
Well-controlled studies with accurate 
methods investigating the eff ects of glove 
punctures on operating room asepsis are 
rare. Christensen and coworkers () 
showed that   of surgeons’ fi ngertips af-
ter cardiothoracic operations were contami-
nated with Gram-positive bacteria. Similar 
results were obtained in  open-heart op-
erations, with   of surgeons’ and scrub 
nurses’ hands having signifi cant amounts 
of skin recolonization at the end of surgery 
(Berg et al. ). In the s, Dodds and 
coworkers investigated the signifi cance of 
surgical glove perforation. Th ey reported 
that glove perforation did not infl uence 
bacterial counts on surgeons’ hands and 
concluded that after standard preoperative 
hand preparation glove perforations are 
of no clinical signifi cance to the patient 
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(Dodds et al. ). However, the study was 
conducted in general surgery, where opera-
tion times are shorter than in heart surgery.
. Antimicrobial prophylaxis
Th e recommended antimicrobial agents for 
cardiothoracic operations include cefazolin 
and cefuroxime (Page et al. ; Gilbert et 
al. ). For patients allergic to beta-lac-
tam agents, vancomycin or clindamycin is 
appropriate (Mangram et al. ). Th e use 
of vancomycin is not generally recommend-
ed, however, because of the risk of develop-
ment of vancomycin-resistant enterococci. 
Long prophylaxis has showed no benefi t 
over short prophylaxis (Niederhäuser et al. 
). Prolonged use of prophylactic agents 
is associated with the emergence of resis-
tant bacterial strains and other infections 
(Harbarth et al. ). Th e consensus of 
the National Surgical Infection Prevention 
Project was that the infusion of the fi rst 
antimicrobial dose should begin within  
min (vancomycin  min) before surgical 
incision and that prophylactic antimicrobial 
agents should be discontinued within  h of 
the end of surgery (Bratzler et al. ). Th e 
drug should be given in an adequate dose 
based on patient’s BMI, and the administra-
tion should be repeated intraoperatively if 
the operation continues two half-lives after 
the fi rst dose to ensure suffi  cient antimicro-
bial levels until wound closure (Forse et al. 
). Although the eff ectiveness of prophy-
lactic antimicrobials in preventing SSIs has 
been shown, their use is often suboptimal. 
In a recent study by Bratzler and coworkers 
(), an antimicrobial dose was adminis-
tered to   of patients within  min before 
incision,   of patients received regimens 
that were limited to recommended agents, 
and antimicrobial prophylaxis was discon-
tinued within  h of surgery ending for only 
  of patients.
Despite the development of techniques 
and eff ective antimicrobial prophylaxis in 
cardiac surgery, there is room for additional 
prophylaxis because deep infections exist 
and multiresistant bacteria have become 
more common. Local antibiotics have been 
widely used in bone and soft tissue infec-
tions (Ipsen et al. ; Jorgensen et al. 
; Stemberger et al. ). As prophylac-
tic agents, they have been used successfully 
in bone cement in total joint arthoplasty 
(McQueen et al. ; Engesaeter et al. 
). Notwithstanding the possible bene-
fi ts of antibiotic-impregnated bone cement 
in joint arthroplasty, its use is controversial 
and no established guidelines for this appli-
cation exist (Bratzler et al. ).
In colorectal surgery, the use of a genta-
micin sponge accomplished a signifi cant 
reduction in postoperative wound infection 
rate and hospital stay (Rutten and Nijhuis 
). In cardiac surgery, local antibiotics 
have not been widely used (Cyba-Altunbay 
and Hamann ; Leyh et al. ), but one 
prospective controlled randomized study 
where topical vancomycin was applied dur-
ing wound closure after median sternotomy 
showed a signifi cant reduction in sternal 
wound infections (Vander Salm et al. ). 
Topical vancomycin may, however, encour-
age the emergence of vancomycin-resistant 
pathogens. Th erefore, some antimicrobial 
agent other than vancomycin that prevents 
mediastinitis would be a good addition in 
heart surgery. For treatment of patients 
with mediastinitis, the gentamicin-collagen 
sponge has been shown to be eff ective. One 
report describes mediastinitis being suc-
cessfully treated with sternum refi xation 
and a gentamicin-collagen sponge (Leyh et 
al. ). Th e advantages of local gentami-
cin are that it does not impair renal function, 
the risk of developing resistant pathogens is 
small, and it has the capacity to kill bacteria 
by inhibiting protein synthesis. It is also ca-
pable of destabilizing bilayered membranes 
of bacteria (Kadurugamuwa and Beveridge 
). Systemically administered, gentami-
cin may be toxic, but when administered 
locally, even at very high concentrations the 
serum concentrations remain well below 
toxic levels. Gentamicin is eff ective against 
S. epidermidis; with local gentamicin, even 
resistant isolates were inhibited (Stemberger 
et al. ).
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3 AIMS OF THE STUDY
Th e objectives of this study were to evaluate the risk factors for mediastini-
tis in the Finnish population and to explore ways of preventing this compli-
cation after cardiac surgery. Specifi c aims were as follows: 
. to compare the usefulness of a conventional bacteriological technique 
with that of particle counting under low level air contamination during 
open-heart operations.
. to determine how often surgical gloves are punctured in cardiac pro-
cedures and to examine the correlation between glove punctures and 
bacterial counts on fi ngertips after surgery.
. to assess a local gentamicin sponge in the prevention of surgical site 
infections in coronary artery bypass grafting surgery.
. to determine the incidence and outcome of and risk factors for medias-
tinitis in a single-center patient population over a ten-year period.
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4 MATERIALS AND METHODS
. Patients
Th is project was carried out at the 
Department of Cardiothoracic Surgery, 
Helsinki University Central Hospital. Th e 
study population consisted of patients un-
dergoing sternotomy or thoracotomy during 
cardiovascular surgery with cardiopulmo-
nary bypass between  and . Most 
surgeries entailed CABG. In Studies I and 
III, only CABG operations were included.
Patient data were gathered prospectively 
in Studies I – III and retrospectively in Study 
IV regarding cases of mediastinitis. For 
each patient, the following information was 
prospectively recorded in the hospital dis-
charge registry and operating room log: age, 
gender, operation code, wound class, ASA 
score, and duration of operation; the NNIS 
risk index was calculated from the last three. 
In the hospital’s Cardiothoracic Surgery Unit 
register, the recorded data comprised BMI, 
New York Heart Association (NYHA) class, 
EF, preoperative hospitalization, urgency of 
the operation (elective, urgent, emergency), 
perfusion time, use of ITA, length of postop-
erative stay in the intensive care unit (ICU), 
hospital stay, transfer to other hospitals, 
and mortality. No major changes in surgical 
techniques occurred during this time span. 
Between  and , the antibiotic pro-
phylaxis was two doses of intravenous (IV) 
vancomycin ( g and  mg) in  h. From 
, CABG patients received antibiotic 
prophylaxis in two doses of IV cefuroxime 
. g in  h. Patients who had undergone 
valve reconstruction or were hospitalized at 
least three days preoperatively also received 
IV vancomycin  mg on two occasions. 
Between July  and September , 
the  patients undergoing CABG surgery 
also received local gentamicin prophylaxis 
(Study III).
. Clothing and draping (Study I)
Th is study included  adult patients who 
underwent open, elective coronary artery 
bypass surgery. Th e mean patient age was 
 (range  – ) years. Preoperative whole 
body shower wash with   chlorhexidine 
emulsion was performed three times on 
consecutive days preoperatively by all pa-
tients. Preoperative skin preparation was 
done three times in the operating theater 
with .  chlorhexidine in   v / v ethyl al-
cohol. Th e operations were carried out via a 
median sternotomy incision. All operations 
were carried out in the same convention-
ally ventilated operating theater with twenty 
changes of air per hour. Th e operating team 
consisted of  ±  persons: always the same 
surgeon and mainly the same staff . Traffi  c 
inside the theater and connecting with the 
outside was minimized. Th e patients were 
randomly allocated to two diff erent systems 
of patient draping and staff  clothing: . Clean 
air suit group, where all personnel working 
in the operating theater wore polypropylene 
clean air suits, and the operating team also 
used nonwoven operating gowns reinforced 
with plastic fi lm in the front and lower parts 
of the sleeves (Mölnlycke Health Care AB, 
S-, Mölnlycke, Sweden). Th e patients 
were covered with plastic foil-laminated im-
permeable drapes with self-adhesive edges; 
. Cotton group, where the operating the-
ater personnel wore cotton shirts, trousers, 
and conventional cotton operating gowns. 
Th e patient was covered with cotton drapes. 
Head covers and masks in both groups were 
disposable types. Operating gloves were 
consistently changed by the surgeon when 
the sternum had been opened. In all opera-
tions, the patient draping was supplement-
ed by incision foil (Steridrape®, M, St. Paul, 
MN, USA).
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. Bacteriological sampling (Study I)
At  randomly selected operations in the 
two groups, -l volumetric air samples 
were taken at the time of incision plus  
and  h later from  cm above the sternal 
wound. A Sartorius fi lter sampler was used 
(Sartorius GmbH, Göttingen, Germany) 
with a capacity of  l / min and equipped 
with  mm pore size gelatine fi lters. Th e 
fi lters were transferred immediately after 
sampling to blood agar plates for incubation 
aerobically for  h at  °C. Th e colonies 
were then counted and typed using conven-
tional clinical bacteriological techniques.
Approximately  h after the incision, 
three pieces of sterile polyvinylalcohol (PVA) 
foam (Mölnlycke Health Care AB, S-, 
Mölnlycke, Sweden),   ×  . cm, were placed 
against the sternal wound surface; two piec-
es on the wall of the wound and one piece on 
the surface of the heart. Two pads were also 
placed against the inguinal wound (done 
for saphenous vein harvesting) surface. Th e 
pads were allowed to absorb to saturation 
and then separately put into Ringer’s solu-
tion supplemented with a ß-lactamase in-
activator (Oxoid SR , Oxoid, Basingstoke, 
UK). Th ey were immediately transported 
to the laboratory to be treated in a Stom-
acher homogenizer (Seward Laboratories, 
London, UK). Th e eluates were spread onto 
blood agar plates, which were incubated 
at   °C for  h, after which the colonies 
were counted and typed. Simultaneously 
with the wound sampling, the incision foil 
was sampled. A cardboard frame (aperture 
 cm) was placed onto the foil between 
the wound and the surgeon (Figure ). Th e 
area in the aperture of the frame was rubbed 
with sterile lecithin – Tween solution (.  
and . , respectively) on a sterile cotton 
swab. Th e specimen was placed in sterile 
.  saline. At the laboratory, the swabs 
were treated with the same technique as the 
wound pads.
Particles (≥  μm) were counted by means 
of a Climet A Particle Analyzer (Climet, 
Redlands, CA, USA)  cm above the wound 
for -min periods starting from the incision 
continually throughout the operation.
. Hand-washing and disinfection 
(Study II)
Th e study population comprised  par-
ticipating surgeons in  consecutive 
open-heart procedures consisting mostly 
of CABG operations with cardiopulmonary 
bypass. Altogether  procedures were 
done via a median sternotomy incision. 
Preoperatively, the hands and arms were 
washed with liquid soap and water for  min 
and dried with disposable paper towels. Th e 
hands were then disinfected by rubbing al-
coholic chlorhexidine ( mg / ml chlorhexi-
dine in   ethanol) on the surfaces of the 
hands in a standardized manner for  min. 
Th e skin of the hands was kept wet during 
the time of rubbing, and additional solution 
was applied on the skin when necessary.
. Bacteriological sampling (Study II)
Altogether  bacterial samples from the 
hands of surgeons were taken both after the 
preoperative hand-washing and disinfec-
tion, and postoperatively immediately after 
the removal of the gloves. Th e samples were 
Figure 2. Layout of operating theater and 
position of investigation sites. 1, particle 
analyzer; 2, incision foil (Figure 1 from 
Study I).
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taken by rubbing the fi ngertips for  min 
against the bottom of two Petri dishes, one 
for each hand, containing  ml of sterile 
physiologic saline solution with appropri-
ate inactivators to neutralize possible rem-
nants of the disinfectant. Th ereafter, the 
samples were transferred into test tubes and 
brought immediately to the laboratory for 
incubation and analysis. After incubation, 
the colony-forming units of bacteria from 
the -ml aliquots of the sampling fl uid and 
its tenfold dilutions were counted. Negative 
growth in  ml of fl uid thus indicated the 
presence of less than  CFU of bacteria on 
the fi ngertips.
. Testing of gloves (Study II)
A total of  pairs of gloves from  par-
ticipating surgeons were checked for holes. 
Th e gloves were changed during the opera-
tion if the surgeon noticed a perforation in 
the glove. Th eir practice was to change only 
the damaged glove. Th e punctures reported 
by the surgeons during surgery were regis-
tered, and all gloves were analyzed for punc-
tures. Th is was done according to European 
standard EN - by fi lling the gloves with 
one liter of water (European Committee for 
Standardisation ). Dripping of water 
was recorded as a puncture. Glove perfora-
tion with a diameter of more than . cm was 
defi ned as large. Th e sites of the punctures 
were also recorded. Th ree types of surgical 
gloves were used: Biogel® (Regent Hospital 
Products, Broxbourne, UK), Ansell Medical 
Gammex® (Ansell Medical, Surbiton, Surrey, 
UK), and Neutralon® (Johnson & Johnson 
Medical Inc., Arlington, TX, USA).
. Gentamicin prophylaxis (Study III)
Th e study population comprised  patients 
who underwent elective CABG. Ten patients 
did not meet the inclusion criteria and fi ve 
refused to participate, leaving  subjects 
(Figure ). In all patients, the operative ap-
proach was through a median sternotomy 
with cardiopulmonary bypass. Th e patients 
were randomized to the gentamicin group 
or to the control group using sealed enve-
lopes. All subjects in the gentamicin group 
gave their informed consent. Patients in this 
group received a  cm  ×    cm gentami-
cin-collagen implant (Gentacoll®, Schering-
Plough, Espoo, Finland), which contains  
mg of gentamicin and  mg of collagen, 
underneath their sternum before wound 
closure (Figure ). Th e implant was cut into 
two or three strips before placement. Th e 
controls’ sternums were closed in a routine 
manner with steel wires, without a gentami-
cin implant. All patients received routine IV 
Figure 3. Formation of study groups (Figure 
2 from Study III).
Figure 4. Cross-sectional view with gentami-
cin-collagen implant underneath sternum 
(implant shown as hatched area) (Figure 1 
from Study III).
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antimicrobial prophylaxis (cefuroxime or 
cefuroxime + vancomycin, section .).
Th e following patient characteristics 
were recorded: age, sex, BMI, underlying 
disease, NYHA class, COPD, preoperative 
serum creatinine, EF, and preoperative hos-
pitalization. Th e operative characteristics 
included antibiotic prophylactics, duration 
of surgery, types of bypass grafts used, num-
ber of bypasses, length of cardiopulmonary 
bypass, aortic cross-clamp time, mediasti-
nal drain discharge, reoperation, duration of 
mechanical ventilation, blood transfusions, 
low output syndrome, stay in ICU, antibiot-
ics administered, and postoperative C-reac-
tive protein (CRP). 
. Cases of mediastinitis (Study IV)
Cases with possible mediastinitis were 
identifi ed from the hospital infection reg-
istry and the hospital discharge registry. 
From the hospital infection registry, we 
also gathered all cases with SSI of the chest 
wound and positive blood cultures. Th e pa-
tients’ charts were then reviewed and cases 
of mediastinitis were confi rmed using CDC 
criteria (Table ). Data collected in a retro-
spective chart review included antibiotic 
prophylaxis, microbiological diagnosis, ra-
diological fi ndings, treatment, and reopera-
tions due to mediastinitis.
. Surveillance of infections
For SSIs, we used the criteria published by 
the CDC. During the hospital stay, patients 
were monitored by cardiac surgeons daily 
for fever, wound discharge, and other evi-
dence of wound infection. All patients were 
followed up for three months after discharge 
from hospital. Diagnosis of mediastinitis 
was made either by a cardiac surgeon or by 
an infection consultant based on clinical 
signs, results of wound and blood cultures 
and computed tomography, positive culture 
from mediastinal tissue, or clinical evidence 
of mediastinitis in surgery. Th e staff  report-
ed all nosocomial infections to the hospital 
infection registry, and infection control 
nurses confi rmed these and entered them 
into the database.
. Statistical methods
Data were analyzed using SPSS (Chicago, IL, 
USA) statistical software. Statistical evalua-
tion of diff erences between the bacteriologi-
cal and particulate contamination levels was 
performed by means of the Wilcoxon two-
sample test (I). For assessment of diff erences 
in frequency of glove perforations, the un-
corrected χ test was used. For comparison 
of the length of operations, Student’s t-test 
was used. Th e Cochran-Armitage trend test 
(StatXact ., CYTEL Software Corporation, 
Cambridge, MA, USA) was used to compare 
bacterial distributions when gloves were in-
tact, had small holes, or had large holes (II). 
In the gentamicin study, univariate analysis 
was performed using χ tests for categoric 
variables and t-tests for continuous vari-
ables (III). In the risk factor study, univari-
ate analyses for categoric variables were cal-
culated with the χ test or Fisher`s exact test, 
as appropriate, and for continuous variables 
with the Mann-Whitney U-test. Odds ratios 
(ORs) were used as an estimate of relative 
risk because the prevalence of SSI was low. 
Multivariate analysis was performed as for-
ward step-wise logistic regression. Values of 
P< . were considered to be signifi cant.
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5 RESULTS
. Air contamination control in the 
operating room
With the alternative garment and textile 
system (cotton group and clean air suit 
group), air counts fell from  to  CFU / m 
(P< .). Contamination of the sternal 
wound was reduced by   and that of the 
leg wound by >  . To give continuous 
contamination feedback throughout the 
operation to theater staff , particle counts 
≥  μm were monitored and visualized. Air 
particle counts decreased rapidly from  
particles / m and stabilized to approxi-
mately  particles / m  when the alternative 
clothing system (clean air suit group) was 
used (P< .) (Figure ).
. Glove perforations and 
postoperative skin fl ora of hands
.. Glove perforations
A total of  gloves were examined for 
holes. During operations, the surgeons 
had punctured and changed altogether  
left-hand and  right-hand gloves. Of the 
 gloves removed at the end of opera-
tions,  were found to be punctured in a 
postoperative water test. Left-hand gloves 
were punctured more often ( ,  /  
gloves) than right-hand gloves ( ,  /  
gloves). At the end of the operation, holes 
were found more often in left-hand gloves 
( times) than in right-hand gloves ( 
times). Th e majority of all punctures ( ) 
were in the three fi rst fi ngers of the left hand. 
Of large punctures,   were located in the 
fi rst two fi ngers of the gloves. Th e gloves of 
principal surgeons were found perforated 
at the end of operations more often ( , 
 /  gloves) than those of assistant 
surgeons ( ,  /  gloves). Th e diff er-
ence was statistically signifi cant (P< .). 
With increasing duration of the operation, 
the frequency of glove perforations as well 
as the occurrence of large holes increased 
(Figure ). In only  operations ( ) were 
both gloves unpunctured. Th e chief surgeon 
had at least one glove perforated in   of 
the operations.
Figure 5. Air particle counts during cardiac 
surgery in cotton and clean air suit clothing 
groups (Figure 2 from Study I).
Figure 6. Rate of punctured gloves by dura-
tion of operation. The actual number of 
broken gloves in each group is shown in the 
respective column (Figure 1 from Study II).
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.. Bacterial counts on surgeons’ 
hands
After the preoperative disinfection of hands, 
bacterial counts were low. No colony counts 
were found in   of hand samples, and in 
  of samples the colony count was less 
than  CFU / ml. In samples taken from 
surgeons’ hands immediately after the op-
eration, the variation in bacterial counts was 
much wider;   ( / ) of all samples 
showed no bacteria, and   ( hands) 
had bacterial counts between  and  
CFU / ml. More than  bacterial colonies 
per milliliter of sampling fl uid were found in 
  ( / ) of hand samples. Th e bacterial 
counts on hands increased with increasing 
operation time (P< .) (Figure ).
. Prophylaxis with local 
gentamicin
Th e two groups of patients were comparable 
with respect to preoperative and operative 
variables. Postoperative SSIs occurred in 
 of  patients (. ) in the study group 
and in  of  patients (. ) in the con-
trol group. Th is diff erence was not statisti-
cally signifi cant (P=.). Th ere were three 
cases of mediastinitis (. ) in the study 
group and fi ve (. ) in the control group 
(P=.). No side-eff ects related to the gen-
tamicin sponge were reported. Diff erences 
between the two groups were not statisti-
cally signifi cant. Gram-positive organisms 
accounted for the majority of isolates in 
both groups. Th e pathogens cultivated from 
the sternal wounds or from blood in both 
groups were mainly S. epidermidis or other 
coagulase-negative staphylococci. Th e 
other pathogens cultured were S. aureus, 
Enterococcus spp., and other Streptococcus 
spp. (Table ).
. Incidence, outcome, and risk 
factors for mediastinitis
.. Study population and cases of 
mediastinitis
A total of    cardiovascular opera-
tions with cardiopulmonary bypass were 
performed during the study period, with 
 case-patients (. ) identifi ed as hav-
ing mediastinitis. Table  shows the types 
of procedures and the rate of mediastinitis 
in each procedure. No trend towards an in-
crease in annual incidence of mediastinitis 
was detected (range . – .  in  – , 
P=.) (Figure ). During the study period, 
the patient population got signifi cantly older 
(mean age . – . years, P< .), and the 
proportion of women increased signifi cantly 
(from   to  , P< .), as did the pro-
portion of patients with ASA >  (from   to 
 , P< .). BMI was slightly higher in men 
than in women (. vs. . kg / m, P< .).
Most of the  case-patients ( ) were 
male, and the majority underwent CABG 
with left internal thoracic artery graft and 
Figure 7. Colony counts on surgeons’ 
hands (cfu / ml) at the end of the operation 
grouped by duration of surgery (Figure 2 
from Study II).
Figure 8. Number of patients undergoing 
cardiac procedures and annual incidence of 
mediastinitis (Figure 1 from Study IV).
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vein grafts ( ). Th e average postoperative 
hospital stay was  days. Diagnosis of me-
diastinitis was made a median of  (range 
 – ) days after surgery. Table  shows the 
diagnostic criteria of mediastinitis. Case-
patients had the following concomitant 
diseases: hypertension  ( ), diabetes 
mellitus  ( ), COPD  ( ), and 
peripheral arterial disease  (. ). Fifteen 
( ) had to be reoperated (most often due 
Table 6. Types of procedures and rates of mediastinitis (Table 1 from Study IV).
Procedure Number Mediastinitis cases Rate
CABG 8540 100 (83 %) 1.2 %
Valve reconstruction 1662 14 (11.7 %) 0.8 %
CABG + valve surgery 457 3 (2.5 %) 0.7 %
Other* 16 3 (2.5 %) 0.2 %
Total 10675 120 1.1 %
CABG = coronary artery bypass grafting
*atrial / ventricular septal defect, arrhythmia surgery, procedures on ascending aorta, and left 
ventricular aneurysm





Positive bacterial culture from mediastinal space 57 (48 %)
Evidence of mediastinitis during surgery or histopathologic examination 81 (68 %)
Fever (> 38 °C), chest pain, or sternal instability 101 (84 %)
Purulent discharge from mediastinal area 64 (53 %)
Organisms cultured from blood or discharge from mediastinal area 86 (72 %)
Mediastinal widening on x-ray 77 (64 %)
Table 5. Numbers of sternal wound infections and types of pathogens cultured in each case 
of infection (Table III from Study III).
Gentamicin group, N=272 Control group, N=270
Infections N Pathogens cultured N Pathogens cultured
Superfi cial incisional 
SSI
6 S. epidermidis (3)
None (3)
8 S. epidermidis (4)
E. faecalis + S. epidermidis (1)
None (3)
Deep incisional SSI 2 S. epidermidis (1)
None (1)
2 S. epidermidis (2)
Sternum osteitis 0  – 1 S. aureus (1)
Mediastinitis 3 S. epidermidis (2)
S. aureus (1)
5 S. aureus (1)
S. haemolyticus + S. epidermi-
dis + E. faecalis (1)
None (3)
Total 11 16
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to bleeding),  ( ) had inotropic support 
for >  h,  ( ) had an intra-aortic bal-
loon pump,  ( ) underwent prolonged 
mechanical ventilation (>  h),  ( ) had 
low output syndrome, and  ( ) under-
went tracheostomy. For antibiotic prophy-
laxis,  /  case-patients ( ) received 
vancomycin,  /  ( ) cefuroxime, 
 /  ( ) cefuroxime with vancomycin, 
and  /  ( ) cephamandol. As for the  
case-patients who received cephalosporin 
prophylaxis,  /  ( ) received it within 
 (median , range  – ) min before inci-
sion. Of the  case-patients who received 
only vancomycin, for  /  ( ) this was 
within  min before incision; in  /  
cases ( ), the infusion started  –  min 
before incision.
.. Microbiology
Microorganisms were isolated from  
case-patients (Table ). For  case-patients, 
the cultures were negative, for , cultures 
were not taken, and for another  informa-
tion was missing. Superfi cial or drain cul-
tures accounted for   of specimens, and 
invasive (mediastinal or blood) cultures for 
 . In  case-patients, the mediastini-
tis was caused by one pathogen, and in , 
more than one. Gram-positives were isolat-
ed from   cultures, and Gram-negatives 
from  . Th e most commonly isolated 
pathogens were S. epidermidis ( case-pa-
tients,  ) and S. aureus ( case-patients, 
 ). Concomitant bacteremia was diag-
nosed in  cases ( ) and was most often 
caused by S. aureus.
.. Treatment of mediastinitis
All case-patients received parenteral anti-
biotic treatment. Eighty-four case-patients 
( ) had surgery for mediastinitis;  
( ) were operated on  –  times ( op-
erations altogether) (Table ). Th e most 
Table 8. Organisms isolated from 109 mediastinitis patients with at least one positive cul-














Staphylococcus epidermidis 52 15 34 7 108 (46 %)
Staphylococcus aureus 22 10 14 13 59 (25 %)
Propionibacterium 6  – 4  – 10 (4 %)
Enterococcus faecalis 3  – 3 1 7 (3 %)
Streptococcus viridans 3  –  –  – 3 (1 %)
Other Gram-positives 5  – 2  – 7 (3 %)
Gram-negative bacteria
Klebsiella sp. 1 4 3  – 8 (3 %)
Acinetobacter sp. 3 2 2  – 7 (3 %)
Pseudomonas aeruginosa 3 3  –  – 6 (3 %)
Enterobacter sp. 1 1 1 1 4 (2 %)
E. coli 2  – 1 1 4 (2 %)
Serratia 2  –  – 1 3 (1 %)
Stenotrophomonas maltophila 2  – 1  – 3 (1 %)
Other Gram-negatives 2  –  –  – 2 (1 %)
Mycoplasma hominis 2 1 2  – 5 (2 %)
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common procedure entailed debridement, 
sternal refi xation, and closed mediastinal 
catheter irrigation ( / ). In  cases, the 
operative procedure included omentoplasty 
or pectoral myoplasty. Of the case-patients, 
 had no surgery for treatment of medias-
tinitis because the sternum was stable, and 
the diagnosis was made by clinical signs, 
computer tomography, and bacterial cul-
tures. Comparing case-patients who under-
went surgery for mediastinitis (N=) with 
those who did not (N=), the proportion in 
which S. aureus was isolated was signifi cant-
ly higher in the surgery group (  vs.  , 
P=.). No diff erence appeared between 
these two groups with regard to when me-
diastinitis was diagnosed or the existence of 
concomitant bacteremia.
.. Risk factors and outcome
Th e operating room log showed the rate of 
mediastinitis to be zero in patients with ASA 
score  –  ( / ) and highest in those with 
ASA score  ( / , . ). It was, however, 
higher in patients with score  ( / , 
. ) than in those with score  ( / , 
. ). Th e mediastinitis rate was not signifi -
cantly higher in patients with an NNIS risk 
index score ≥  than in those with a score <  
(.  vs. . , P=.).
Characteristics of patients with and with-
out mediastinitis are shown in Table . Th e 
rate of mediastinitis was higher in males 
than in females (.  vs. . , P< .), and 
while mediastinitis patients were no older 
than non-mediastinitis patients, they did 
have a higher BMI. Th eir operation times 
also tended to be longer. In the three BMI 
categories of < ,  – , and >  kg / m, 
the mediastinitis rates were . , . , and 
. , respectively. Of the variables entered 
into multivariate logistic regression analy-
sis (age, sex, BMI, operation year, perfusion 
time, type of procedure), only BMI was an 
independent risk factor (OR .,   CI 
. – ., P< .). With mediastinitis, hos-
pital stay was signifi cantly longer, and more 
patients were transferred to other hospitals. 
Th e -day mortality did not diff er between 
patients with and without mediastinitis, nor 
did one-year all-cause mortality (Table ).
Table 9. Treatment of mediastinitis in case-patients (N=120) classifi ed into fi ve types accord-
ing to El Oakley and Wright (1996).


























Type I (presenting within 2 
weeks)
23 (19 %) 5 18  –  – 1
Type II (presenting at 2 – 6 
weeks)
15 (13 %) 5 7* 1 2  – 
Type III (types I – II in the 
presence of risk factors)
60 (50 %) 24 29† 4 3 3
Type IV (mediastinitis requir-
ing two or more operations)
17 (14 %)  – 13 17 12 4
Type V (presenting > 6 weeks 
after operation)
5 (4 %) 2  – 1 2 1
MODS = multiple organ dysfunction syndrome. * In 1 case combined with pectoral myoplasty. † In 2 
cases combined with pectoral myoplasty
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Age (years) 61.3 ± 9.2 62.5 ± 10.8 0.127
Male gender 95 (83 %) 7570 (71 %) 0.008
BMI (kg / m2) 29 ± 5 27 ± 4 <0.001
NYHA III – IV 48 (76 %) 4529 (75 %) 0.805
Ejection fraction ( %) 54 ± 15 54 ± 15 0.784
Preoperative hospitalization (days) 1.8 ± 1.2 1.8 ± 2.3 0.245
Intraoperative characteristics
Urgent surgery 6 (5.2 %) 732 (6.9 %) 0.477
Perfusion time (min) 100 ± 37 101 ± 43 0.774
Operation time (min) 220   ±   65 214 ± 64 0.306
Bilateral ITA 6 (5.2 %) 691 (6.5 %) 0.573
Postoperative stay in ICU 2.6 ± 3.5 2.1 ± 4.7 0.274
Postoperative characteristics
Days hospitalized after surgery 22 ± 17 9 ± 5 <0.001
Transferred to another hospital 34 (38 %) 2232 (26 %) 0.010
30-day mortality 1 (0.9 %) 168 (1.6 %) 0.540
1-year mortality 10 (8.7 %) 629 (5.9 %) 0.214
BMI = body mass index; NYHA = New York Heart Association; ITA = internal thoracic artery; ICU = 
intensive care unit.
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6 DISCUSSION
Th e objectives of this thesis were to inves-
tigate ways of preventing SSI after cardiac 
surgery and to evaluate incidence and risk 
factors for poststernotomy mediastinitis. 
Mediastinitis as a complication following 
cardiac surgery is rare, but disastrous. It 
increases hospital costs, causes suff ering to 
patients, and prolongs hospital stay mark-
edly. Because SSIs are most often sequelae 
from contamination during surgery, exam-
ining the operating room environment to 
keep the contamination level as low as pos-
sible is warranted. Th is is why we have stud-
ied air contamination monitoring, glove 
perforations, and fi ngertip bacteria. Local 
antibiotic prophylaxis seems to be a sensible 
means of preventing SSIs after cardiac sur-
gery and is also economically sound, since 
the treatment of mediastinitis is extremely 
expensive. Performing studies in cardio-
thoracic surgery where the infection rate is 
very low is challenging, time-consuming, 
and demands large study populations to get 
signifi cant results. Changes in the popula-
tion at risk, with, for example, the increasing 
prevalence of overweight patients, reinforce 
the importance of surveillance and pose a 
continuous challenge in focusing preven-
tive measures.
. Incidence and mortality of 
mediastinitis
Th e rate of mediastinitis that we detected 
(. ) is in line with that of other large stud-
ies performed since the s (Table ). Th e 
risk was slightly higher in CABG procedures 
(. ) than in valvular surgery (. ).
Less than   of our patients with me-
diastinitis died within one month of car-
diac surgery, and   died within one year. 
Mortality did not diff er between patients 
with and without mediastinitis. Th e treat-
ment of mediastinitis is thus effi  cient, and 
although quite expensive, worth the cost. 
Increased early mortality has been associat-
ed with mediastinitis (Loop et al. ; Valla 
et al. ; Gårdlund et al. ; Fowler et 
al. ), but a few studies also show in-
creased long-term mortality (Milano et 
al. ; Braxton et al. ; Lu et al. ; 
Toumpoulis et al. ). Such diff erences 
may be related to the causative microbes. In 
two studies with mortality rates of   and 
 , the pathogens involved were mainly 
S.  aureus and P. aeruginosa (Ottino et al. 
; Wouters et al. ), while mediasti-
nitis caused predominantly by coagulase-
negative staphylococci showed low mortal-
ity ( –  ) (Antunes et al. ; Ståhle et al. 
; Bitkover and Gårdlund ). Among 
our mediastinitis patients, the most com-
monly isolated pathogen was S. epidermi-
dis and then S.  aureus. Pathogens involved 
in SSIs after cardiac surgery are usually 
S.  epidermidis and S.  aureus (Th e Parisian 
Mediastinitis Study Group ; Tegnell et 
al. ; Sharma et al. ). Coagulase-
negative staphylococci have recently be-
come an important pathogen, especially in 
deep infections (Tegnell et al. ).
. Preventive methods
.. Air contamination control
Th e seriousness of postoperative infections 
and the increased susceptibility of patients 
undergoing cardiac surgery increase the 
demand on operating theater asepsis to 
prevent even low infecting doses of bacte-
ria from reaching the wound. Evidence of 
the prophylactic eff ects of diff erent aseptic 
measures in diff erent operations is limited, 
with the most data found for orthopedic en-
doprosthetic operations. Whyte et al. () 
have shown that a considerable amount of 
34 HUCH, Jorvi Hospital Publications • Series A 01/2006
organisms carried by air reach the wound 
after sedimentation onto a sterile fi eld. Th ey 
also presented a model to clarify the pat-
terns of transfer.
Figure  shows that use of the clean air 
suit system results in a signifi cantly lower 
level of air particle counts at the beginning 
of the operation. A low level of total par-
ticles and corresponding bacteria carrying 
particle count off er an important possibility 
for individual operation air contamination 
follow-up.
When the level of air contamination is 
high, a poor correlation has been demon-
strated between the number of particles 
sized  –  μm and microbial contamination 
(Seal and Clark ). Low particle counts 
≥  μm should allow indirect estimations of 
air bacteria carrying particle counts dur-
ing the entire operation. Th e low level of 
particle counts, when achieved, would also 
mean a low level of particles carrying bacte-
ria. As part of total air particles size is ≥  μm, 
the bacteria carrying particles demonstrate 
less than  . Th e low air contamination 
was achieved even in an ordinary ventilated 
theater when individual team members 
used clean air suits in combination with im-
permeable patient drapes. When air particle 
level ≤  particles / m is reached, the bacte-
rial air contamination is of the order of that 
of orthopedic hip operations. Th e staff  must 
during the entire operation adjust their ac-
tivity to air asepsis.
Verkkala and coworkers () have re-
ported earlier on the eff ect of experimental 
conditions on air cleanliness. Even if the air 
contamination here is low (. CFU / m), 
the eff ect of the clean air suit system is clear 
(. CFU / m). Th e diff erence then corre-
sponds well with the lower degree of con-
tamination observed on the incision foil, in 
the sternal wound, and in the leg wound. 
Th e highest reduction was found on the in-
cision foil, probably owing to both reduced 
sedimentation and a better barrier eff ect 
against the patient’s own skin bacteria via 
contact transfer. Th e important result of this 
study is that when low levels of operative air 
contamination were achieved, continuous 
on-line air contamination information to 
the operating team throughout the opera-
tions could be generated.
.. Glove perforations
Contamination of the wound can happen 
through perforated surgical gloves; the fre-
quency of these perforations is quite high. 
Studies conducted during surgical proce-
dures have demonstrated glove perforation 
rates ranging from   in ophthalmologic 
surgery to   in general surgery (Nakazawa 
et al. ; Brough et al. ; Dodds et al. 
; Albin et al. ; Chapman and Duff  
). Greater than   leak rates have 
been reported for cardiovascular, orthope-
dic, and abdominal surgeries (Albin et al. 
). Th e puncture rate depends on the 
type of surgery and the skill of the surgeon. 
Th e risk of glove tears in orthopedic surgery 
may be especially high because of sharp in-
struments and jagged bone fragments. Th e 
risk of glove perforation increases with the 
length of the surgery. Th ree studies report 
glove perforations increasing by an addi-
tional   for procedures lasting more than 
 h (Gani et al. ; Laine and Aarnio , 
). Th is is in line with our fi nding of more 
punctures occurring with longer operations 
(II). In operations lasting over  h,   of 
gloves were perforated, and the fi ngertips of 
the surgeons were contaminated with large 
numbers of bacteria. Th is combination 
can be dangerous to the patient regarding 
wound asepsis.
It is common practice to change a glove 
when it is punctured. However, the diffi  cul-
ty is that surgeons may not notice the tear. 
In our study, the surgeons noticed glove 
holes and subsequently changed the glove 
 times during operations. However, the 
gloves removed after operations were often 
punctured; in  of  gloves, holes were 
detected in the water test. Th e surgeons 
detected only   of these punctures ( 
of the  punctured gloves). In previous 
studies, the detection rates of tears have 
varied from   to   (Berg et al. ; 
Chapman and Duff  ; Laine and Aarnio 
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). When the double-gloving system is 
used, the detection rate is   (Laine and 
Aarnio ). Left-hand gloves were punc-
tured more often than right-hand gloves. 
Half of the holes were found in the fi rst 
three fi ngers of the left-hand glove. Of large 
punctures,   were located in the fi rst two 
glove fi ngers. Th is is hardly surprising, nor 
is the fi nding that the gloves of principal 
surgeons were perforated more often than 
those of assistant surgeons. Th e latter fi nd-
ing is in agreement with the study of Whyte 
et al. (), in which the glove puncture 
rate for surgeons was   and for assistant 
surgeons  .
It is worrisome that despite the develop-
ment of glove materials, gloves were found 
unpunctured in only   of all operations, 
and the chief surgeon had at least one per-
forated glove in   of operations. Glove 
holes were rated as large in   of cases. 
It seems logical to assume that such a high 
glove breakage rate would considerably 
increase the infection risk. Our study does 
not, however, support this assumption be-
cause the glove holes did not seem to have 
a straightforward relationship with infec-
tion rates. Today, the skin of the patient is 
diligently disinfected, in Europe most of-
ten with effi  cient alcoholic preparations, 
the patients receive preoperative antibi-
otic prophylaxis, and the surgery is elective, 
whenever possible. Th e infection is a conse-
quence of multiple causative factors, with 
the bacteria from the surgeon’s hands be-
ing only one of these. Patients’ sternal skin 
has been shown to be the main source for 
wound contamination with epidemic MRSE 
bacteria (Tammelin et al. b). Th e same 
bacteria on the hands of the operating staff  
were not a risk factor for their occurrence in 
the wound at the end of the operation. Th is 
is consistent with statements from two other 
studies that glove punctures did not increase 
the risk for postoperative wound infection 
(Cruse and Foord ) or wound contami-
nation (Whyte et al. ). Dodds found 
glove perforations in   of operations and 
concluded that after standard preoperative 
hand preparation, glove perforations are of 
no clinical signifi cance to the patient, and 
that protection of the surgeon is the main 
indication for a per operative change of 
damaged gloves. However, the operations 
in that study were general surgery and the 
operation times were shorter than in heart 
surgery (Dodds et al. ). We were not 
surprised that we were unable to confi rm the 
correlation between glove perforations and 
elevated infection risk. Th e development of 
a wound infection is a complex and multi-
factorial issue, and our subject pool was not 
suffi  ciently large to thoroughly study various 
factors predisposing to SSIs. Although we 
were not able to prove increased infection 
risk, we did confi rm that bacterial counts on 
hands increased with increasing length of 
the operation. Th e glove puncture rate also 
increased.
If preoperative hand disinfection is done 
properly and for suffi  ciently long, modern 
disinfection techniques effi  ciently reduce 
bacterial counts on hands. Some microbes 
may remain on the skin, but wearing surgi-
cal gloves probably prevents their escape 
into the wound. In our study, more than half 
of the hands were recolonized at the end of 
the operation, probably because of bacteria 
multiplying in the crypts of sebaceous glands 
and hair follicles. We found that some doc-
tors had no or scant bacteria on their hands 
either before or after the operation, while 
the postoperative bacterial counts of others 
were quite high. Th is is likely due to personal 
skin problems, such as dermatitis, dry skin, 
or small scratches. In addition, in long and 
complex procedures, surgeons may injure 
their skin when making sutures. Th ese small 
wounds may potentially become the source 
for small amounts of serum and extracellu-
lar fl uid being released under the glove and, 
in case of leakage, may become a possible 
route for microbes to be transferred from 
the surgeon to the patient, or vice versa.
Since bacteria on the skin of the hands 
increase with time, it is not unreasonable to 
suggest that when gloves are changed be-
cause of a tear, the hands should also be dis-
infected before donning new gloves. Also, as 
glove holes tend to go undetected, changing 
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both gloves when one glove is torn should 
be the practice of choice.
.. Prophylaxis with local 
gentamicin sponge
In our prospective, randomized study with 
a gentamicin-collagen implant (III), no 
signifi cant diff erence was found between 
infection rates of the two groups. At the very 
least, we can say that locally administered 
gentamicin did not increase the SSI rate, 
which was   in the gentamicin group and 
  in the control group. Th e occurrence of 
mediastinitis was also slightly lower in the 
study group (.  vs. . ). Th is kind of 
prophylaxis has not been investigated be-
fore the year . Friberg et al. () have 
recently published a prospective, random-
ized trial using prophylactic gentamicin-
collagen sponges between sternal edges in 
 cases undergoing open-heart surgery. 
Th e incidence of SSI was signifi cantly re-
duced, from   to . , but in the case of 
osteitis or mediastinitis (.  vs. . ), the 
diff erence was not statistically signifi cant. 
Here, we can see a possibility of reducing 
SSIs, but further research related to medias-
tinitis is needed.
Th e gentamicin-collagen implant was 
very safe. Neither allergic reactions nor im-
pairment in renal function occurred. We did 
not, however, determine plasma levels and 
drainage fl uid levels of gentamicin in this 
study. With the gentamicin sponge, high lo-
cal gentamicin levels (>  mg / l) for  h 
have been detected in mediastinal eff usions 
(Leyh et al. ; Friberg et al. ). Th e 
minimum inhibitory concentration (MIC) 
of gentamicin is  mg / l. Th e local peak lev-
els of gentamicin are  –  times higher 
than the MIC (Leyh et al. ). We do not 
know how long gentamicin remains in me-
diastinal tissue, but release is dependent on 
the local blood fl ow. High bactericidal gen-
tamicin levels are detected even  h after 
surgery (Leyh et al. ). Since many risk 
factors for infection have been identifi ed, 
targeting additional measures to the patients 
at highest risk is advisable. Local antimicro-
bial agents, such as the gentamicin-collagen 
sponge, may be most benefi cial in high-risk 
patients. If the gentamicin-collagen implant 
also prevents SSIs in larger studies, it would 
be cost-eff ective to use gentamicin-collagen 
implants in every CABG patient since the 
treatment of mediastinitis is extremely ex-
pensive.
. Risk factors for mediastinitis
Results regarding risk factors for SSIs in 
other large studies are confusing. Th e data 
are mostly from the s and s (Table 
). Only a few studies are more recent. Th e 
studies are long-term, up to  years. Several 
shorter studies, which have smaller popula-
tions, multicenter studies, or case-control 
studies have also been published. Some 
research concentrates only on mediastinitis 
and some on all sternal infections. In most 
studies, data have been entered prospec-
tively in registers, but the collection of infec-
tion data is retrospective. A few completely 
prospective studies and some case-control 
studies are also available. Th ey often focus 
on diff erent risk factors, depending on what 
data have been collected in registers. Th e 
defi nitions of infections may vary. Even di-
agnosing mediastinitis can be diffi  cult.
Th e only predictive factor found for me-
diastinitis here was obesity. Obesity has 
previously been shown to predispose not 
only to superfi cial sternal infection but also 
to mediastinitis (Loop et al. ; Milano et 
al. ; Th e Parisian Mediastinitis Study 
Group ; Valla et al. ; Antunes et 
al. ; Bitkover et al. , Abboud et al. 
; Harrington et al. ; Fowler et al. 
). Our rate of mediastinitis was almost 
three times as high in patients with BMI 
>  kg / m as in those with BMI <  kg / m. 
Similarly, in a French study, the rate of me-
diastinitis was .  with BMI ≥  kg / m, 
compared with .  with BMI <  kg / m 
(Th e Parisian Mediastinitis Study Group 
). Th e increased risk for mediastinitis 
in obese patients may be related to such 
factors as technical diffi  culties during sur-
gery, prolonged operation time, increased 
37HUCH, Jorvi Hospital Publications • Series A 01/2006
bleeding, and ineff ective prophylactic anti-
biotic dose (Milano et al. ). Overweight 
is also associated with type II diabetes 
mellitus and metabolic syndrome. Several 
groups have observed an increased risk for 
mediastinitis among diabetics undergoing 
cardiac surgery (Loop et al. ; Wouters 
et al. ; Valla et al. ; Antunes et al. 
; Ståhle et al. ; Trick et al. ; Lu 
et al. ; Harrington et al. ; Fowler et 
al. ). Of our mediastinitis patients,   
had diagnosed diabetes. Due to incomplete 
documentation in postdischarge diagnoses 
and the cardiothoracic register, and lack of 
systematic information on peri- or postop-
erative glucose levels we could not, however, 
evaluate diabetes as a risk factor. More recent 
studies show that undiagnosed diabetes and 
postoperative hyperglycemia are also as-
sociated with development of SSIs, and that 
perioperative continuous intravenous insu-
lin infusion can lower the incidence of deep 
sternal infection in diabetic patients during 
cardiac surgery (Furnary et al. ; Trick et 
al. ; Latham et al. ), a fi nding with 
important practical implications for preven-
tion. Th ese results were not available during 
our study period.
Th is study represents our single-center 
experience over a -year period. Th e limi-
tations of this study are associated with its 
long time span and the changes that have 
occurred during this period. Cardiac sur-
gery increased until , and then started 
to decrease due to more active cardiologists. 
Th e annual number of cardiac operations 
doubled from  in  to  in . 
Changes in technique and patient popula-
tion over time, such as the increased num-
ber of older and sicker patients, may have 
an impact on the results. Equipment and 
techniques have developed, but the CABG 
procedure has basically remained the same. 
More radial arteries as grafts are used than 
at the beginning of the s. No changes 
have taken place in operating room practic-
es, except in antibiotic prophylaxis. Treating 
perioperative hyperglycemia with insulin 
infusion is probably more common today.
Looking at the whole population as one 
entity is also controversial. In our opinion, 
there are several kinds of mediastinitis. Th ey 
can be due to contamination during surgery, 
hematogenous spread from other focuses or 
infection spreading from subcutaneous tis-
sue to the mediastinal space. Fragmentation 
of the sternum can lead to mediastinitis if 
sawing is oblique or the patient’s coughing 
breaks the sternum. Mediastinitis can vary 
from mild to severe. El Oakley and Wright 
() have classifi ed mediastinitis into fi ve 
types according to time of diagnosis, risk 
factors, and number of reoperations (Table 
). Th is classifi cation was supported by our 
subject pool, mediastinitis types I – II being 
less severe and having better outcome than 
types III – V. Gårdlund and colleagues () 
suggested three types of mediastinitis; the 
fi rst type associated with obesity, COPD, 
and sternal dehiscence typically caused 
by S.  epidermidis, the second type follow-
ing perioperative contamination and of-
ten caused by S. aureus, and the third type 
caused by infections at other sites by Gram-
negative rods. Th e results of our study sup-
port the assumption that mediastinitis has 
various etiologic factors since we found only 
obesity to be a predisposing factor.
Essentially, all of our patients with medi-
astinitis ( ) received antimicrobial pro-
phylaxis, but there is still room for improve-
ment, especially in its timing. Of patients 
who received prophylaxis,   did not 
receive it within  min ( min for van-
comycin) before incision. Previous studies 
have demonstrated that timing is critical for 
eff ective prophylaxis, with current guide-
lines recommending dosing within  min 
before incision (Bratzler et al. ). More 
than half of our patients received only van-
comycin, most likely to cover methicillin-
resistant coagulase-negative staphylococci. 
We found that vancomycin infusion was of-
ten initiated rather close to incision and that 
the dose might have been insuffi  cient, espe-
cially in obese patients (Forse et al. ). 
Data available in our operating room log 
included no information on type and timing 
of antimicrobial prophylaxis, so these could 
not be studied as risk factors.
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Risk for mediastinitis did not increase di-
rectly with ASA and NNIS risk scores. Roy et 
al. () also showed that duration of the 
procedure was the only component of the 
NNIS index that stratifi ed patients undergo-
ing cardiothoracic operations by risk for SSI. 
Th eir study, however, included all SSIs, not 
only mediastinitis.
CABG has been verifi ed as a risk factor 
for infection (Th e Parisian Mediastinitis 
Study Group ; Muñoz et al. ; 
Ståhle et al. ), probably due to using 
ITA as bypass graft material, compromis-
ing sternal blood fl ow (Seyfer et al. ; 
Carrier et al. ). Harvesting both ITAs, 
in particular, has been shown to increase 
infection rates (Grover et al. ; Antunes 
et al. ; De Paulis et al. ). However, 
if ITAs were harvested skeletonized, no in-
crease in infection risk occurred (De Paulis 
et al. ). Diabetes was not a predictor of 
deep sternal wound infection in patients re-
ceiving bilateral skeletonized ITA (Matsa et 
al. ; Peterson et al. ; Lev-Ran et al. 
; De Paulis et al. ). In our patients 
who developed mediastinitis, we had used 
both ITAs rarely ( ), and the proportions 
between patients with and without medias-
tinitis did not diff er.
Our patient population undergoing car-
diac surgery during the last decade had 
changed substantially. Th is was most likely 
due to an increasing number of patients 
having nonoperative cardiac procedures in-
stead of CABG. Christakis et al. () found 
incidence of CABG-associated morbidity 
and mortality to increase in parallel with the 
number of elderly patients, patients with 
previous CABG procedures, and patients 
undergoing urgent operations. We did not 
observe similar trends, although our pa-
tients had become signifi cantly older and an 
increasing proportion had an ASA score of  
or . In addition, the proportion of females 
had increased. Th is can in part explain our 
fi ndings since risk for mediastinitis was low-
er in females. Previously, either gender has 
been a risk factor for SSI after cardiac sur-
gery, depending on the site and type of SSI 
(Roy ). Our male patients had a slightly 
higher BMI, but gender was not an indepen-
dent risk factor in multivariate analysis. Age 
has been verifi ed as a risk factor for SSIs in 
many types of surgeries (Scott et al. , 
Kaye et al. ). However, several cardiac 
surgery studies have shown that age does 
not predispose to sternal infections (Ottino 
et al. ; Hammermeister et al. ; Loop 
et al. ; Th e Parisian Mediastinitis Study 
Group ; Antunes et al. ; Muñoz et 
al. ; Ståhle et al. ), which is consis-
tent with our fi ndings.
Our study was based on a retrospective 
chart review, and to evaluate incidence and 
potential risk factors, we utilized data up-
loaded from four separate in-hospital data-
bases: the hospital discharge register, hospi-
tal infection register, operating room log, and 
a register kept by cardiothoracic surgeons. 
Linkage of several databases at the patient 
level was problematic, and only a limited 
number of variables could be included in 
our fi nal analysis. For example, in addition 
to diabetes and blood glucose levels, several 
other known risk factors for infection, such 
as tobacco or concurrent corticosteroid use, 
could not be investigated.
Our results indicate that the rate of me-
diastinitis is not decreasing. Changes in the 
population at risk, with, for example, an in-
creasing prevalence of overweight patients, 
reinforce the importance of surveillance 
and pose a continuous challenge in focusing 
preventive measures. Planning and selec-
tion of data fi elds included and compulsory 
in diff erent hospital information systems 
require research of potential infection con-
trol interventions for more effi  cient disease 
prevention.
. Summary
We found obesity to be an independent 
predictor of mediastinitis in our large sub-
ject pool comprising over   patients. 
Moreover, we showed that a clean air suit 
results in low theater air contamination 
and low exogenous contamination of the 
operating wound. Continuous particle 
monitoring proved to be a good intraopera-
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tive method to control air contamination. 
Frequent glove perforations were found to 
form a possible contamination route be-
cause of exponentially multiplying bacteria 
on surgeons’ fi ngertips. We presented a lo-
cal antimicrobial prophylaxis which may be 
benefi cial when performing sternotomy on 
high-risk patients.
Despite modern surgical techniques 
and our knowledge of the pathogenesis of 
SSIs and the use of perioperative antibiotic 
prophylaxis, the incidence of SSIs has not 
decreased, but has remained at the same 
level (IV). More eff ective preventive meth-
ods are thus needed and will likely become 
even more important in the future due to 
older and sicker patients, the population 
becoming increasingly obese, type II diabe-
tes becoming more common, and the emer-
gence of resistant bacteria. Every possible 
prevention method must be considered and 
those proven to be effi  cient taken into prac-
tice. Patients coming to surgery should be 
encouraged to lose weight and stop smok-
ing before surgery. Bacterial contamination 
must be kept as low as possible via preop-
erative preparation of the patient, including 
proper timing of hair removal and careful 
skin preparation with topical antiseptics. 
Adequate dosing and optimal timing of an-
timicrobial prophylaxis must be considered. 
Local antibiotics can also be used. Airborne 
contamination should be minimized by ef-
fective ventilation in the operating room and 
by use of impermeable scrub suits by staff . 
Strict aseptic hygiene during operations to-
gether with minimal traffi  c in and out of the 
operating room is mandatory. Maintaining 
homeostasis during operations is critical, 
including perioperative control of blood 
glucose. Th e use of   oxygen should also 
be considered. Finally, surveillance of SSIs, 
with reports of surgeon-specifi c SSI rates, is 
warranted.
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7 CONCLUSIONS
On the basis of Studies I – IV, the following conclusions can be drawn: 
. In a conventionally ventilated operating theater, the use of clean air suits 
and impermeable patient clothing eff ectively reduces dispersal of organ-
isms from the operating team, resulting in low theater air contamination 
and low exogenous contamination of operating wounds. Continuous 
particle monitoring is a good intraoperative method to control air con-
tamination related to theater staff  behavior during individual opera-
tions. Th is method increases the possibilities of studying the theaters, 
technical designs, materials, and methods with a view towards lower 
contamination levels, and also enables the evaluation of larger groups 
of patients regarding the risk for wound infection.
. Glove perforations occur in the majority of heart operations. Th e fre-
quency of glove perforations and bacterial counts on hands increase 
with operation time. When a puncture is detected, both gloves should 
be changed. Before donning a new pair of gloves, renewed disinfection 
of hands will help to keep bacterial counts low, particularly towards the 
end of a long operation.
. Th e gentamicin-collagen sponge can safely be used as antimicrobial 
prophylaxis in CABG surgery, with slightly less SSIs occurring in the gen-
tamicin group. Th e sponge may have benefi cial eff ects on the prevention 
of SSIs after cardiac surgery, but our series was too small to allow any 
fi rm conclusions to be made.
. Th e rate of mediastinitis is not decreasing. Th e main predictive factor 
found for mediastinitis was obesity. Mortality did not diff er between pa-
tients with and without mediastinitis. Changes in the population at risk, 
with, for example, an increasing prevalence of overweight patients, rein-
force the importance of surveillance and pose continuous challenges in 
focusing preventive measures.
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